Colorescience has announced the results of a new study on facial redness, associated with skin conditions such as rosacea. 

The 18-week study, published in The Journal of Cosmetic Dermatology, assessed the efficacy and tolerability of a topical skin care regimen alone and in combination with Intense Pulsed Light Therapy (IPL) to improve facial redness associated with skin conditions such as rosacea and decrease post-treatment side effects.

The topical skin care regimen participants used in the study is Colorescience’s All Calm Clinical Redness Corrector SPF 50 and Sunforgettable Brush-On Shield SPF 50, which are both shown above. 

The study demonstrated that the topical products worked, alone and in conjunction with an IPL treatment. The All Calm Clinical Redness Corrector is a 3-in-1 proprietary formula that instantly neutralizes the appearance of redness, while soothing and calming sensitive skin. Its patent-pending “BioSolace” complex helps provide ongoing relief from sensitivity and the appearance of redness. Sunforgettable Brush-On Shield provides total protection against UVA/UVB rays, blue light (HEV), pollution, and infrared heat. 

Clinical study investigator, Jennifer Deaver Peterson, MD of The Pearl Dermatology in Houston, TX, states, “The study showed that this regimen can achieve significant improvement for patients who suffer with facial redness. Having products like these that work alone or in combination with office-based procedures is a game changer for aesthetic practices.”

Patricia Boland, vice president, Research and Development, Colorescience, comments, “Our mission is to develop unique products that improve patient experiences, enhance outcomes and protect skin health. We are pleased that these results are consistent with our other published data and what our physician partners see in practice.”

More Details About the Study

During the study, twenty patients used the Colorescience products described above as a daily topical skin care regimen for 12 weeks. At week 12, those same patients received a single IPL (M22 Lumenis) treatment immediately followed by the application of the same skin care products and then continued the topical skin care regimen for 6 additional weeks.

All patients reported their skin looked better immediately following the application of the skin care products across all time points, including immediately post-IPL.

At week 18, the overall mean redness score significantly improved by 33% from baseline (p<0.01). This study demonstrates that the skincare regimen applied immediately post IPL and in combination with an IPL treatment produced a significant reduction in overall facial redness in patients with rosacea.

The study was conducted at the office of Suzanne Bruce and associates by investigators Jennifer Deaver Peterson, MD and Tracy M. Katz, MD of The Pearl Dermatology.

Photos: via Colorescience